Professional Overview
Basil Blakeney is an experienced finance executive with over 10 years of demonstrated leadership in the pharmaceutical industry. As the Finance Director at AbbVie Limited, he oversees all financial operations and strategic decision-making to drive organizational growth and profitability.
Experience Summary
Current Role
As the Finance Director at AbbVie Limited since 2012, Basil is responsible for managing the company's financial resources, reporting, and analytical functions. He plays a pivotal role in aligning financial strategies with business objectives, ensuring operational efficiency and regulatory compliance. Under his leadership, AbbVie has achieved significant year-over-year revenue growth of 8% and improved its profit margins by 12%.
Career Progression
Prior to joining AbbVie, Basil held various finance roles of increasing responsibility within the pharmaceutical sector. He started his career as a Financial Analyst at Pfizer Ireland, where he provided critical data analysis and reporting to support strategic decision-making. Basil then progressed to become the Senior Financial Controller at Merck Sharp & Dohme, where he contributed to the successful integration of acquired entities and the implementation of enhanced financial processes.
Academic Background
Basil holds a Bachelor's degree in Accounting from University College Dublin and a Master's degree in Finance from the University of Limerick. He is also a Certified Public Accountant (CPA) and a member of the Chartered Institute of Management Accountants (CIMA).
Areas of Expertise
- Financial planning and analysis
- Budgeting and forecasting
- Cost optimization and process improvement
- Financial reporting and regulatory compliance
- Strategic financial decision-making
- Cross-functional team leadership
Professional Impact
Basil has a proven track record of driving financial and operational excellence in the pharmaceutical industry. He has successfully led the implementation of a new enterprise resource planning (ERP) system at AbbVie, resulting in a 20% improvement in financial reporting efficiency. Basil has also been recognized for his contributions to industry associations, having served on the board of the Irish Pharmaceutical Finance Association.
Conclusion
With his extensive finance expertise and deep industry knowledge, Basil Blakeney is a valuable asset to AbbVie Limited. He is committed to leveraging his financial acumen and strategic leadership to support the company's continued growth and profitability in the evolving pharmaceutical landscape.
